Linac-based intensity modulated total marrow irradiation (IM-TMI)

Area of Science:

• Radiation Oncology
• Medical Physics
• Hematology

Background:

• Total body irradiation (TBI) is a standard systemic therapy for hematological malignancies and a pre-conditioning regimen for bone marrow transplantation.
• Conventional TBI techniques often lead to significant acute and chronic toxicities due to the irradiation of large volumes of normal tissues.
• Intensity modulated radiation therapy (IMRT) offers precise dose conformity, potentially reducing side effects and enabling higher radiation doses.

Purpose of the Study:

• To investigate the feasibility of a linear accelerator (linac)-based approach for intensity modulated total marrow irradiation (IM-TMI).
• To identify and discuss the clinical implementation challenges associated with linac-based IM-TMI.
• To explore the potential of IM-TMI to reduce radiation-related sequelae compared to standard TBI.

Main Methods:

• Development and investigation of a linac-based system for intensity modulated total marrow irradiation (IM-TMI).
• Evaluation of technical feasibility for precise dose delivery to the entire marrow space.
• Analysis of challenges pertinent to clinical integration and patient management.

Main Results:

• The study explores the technical feasibility of linac-based IM-TMI.
• Identified challenges for clinical implementation are discussed.
• Potential for dose escalation and toxicity reduction is highlighted.

Conclusions:

• A linac-based approach to intensity modulated total marrow irradiation (IM-TMI) shows promise for improved cancer treatment.
• Successful development could significantly reduce the incidence and severity of complications associated with current total body irradiation (TBI) techniques.
• Further research and development are needed to overcome clinical implementation challenges.